Clinical Trial Update: Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of oltipraz in liver fibrosis and cirrhosis has completed. Sponsor: HK inno.N Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Liver Fibrosis

Drugs mentioned

• Oltipraz (oltipraz)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Liver Fibrosis, Liver Cirrhosis | Phase 2 | Status: COMPLETED